Stuart C. Gordon
Impact in
- Hepatology top 0.01%
- Hepatitis C virus research
- Liver Diseases and Immunity
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Liver physiology and pathology
- Epidemiology top 0.2%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 259
- Hepatitis C virus research 193
- Liver Diseases and Immunity 44
- Liver Disease and Transplantation 17
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Epidemiology 92
- Hepatitis B Virus Studies 53
- Liver Disease Diagnosis and Treatment 38
- Co-authors
- Janice K. Albrecht (22 shared papers)John G. McHutchison (37 shared papers)Mitchell L. Shiffman (7 shared papers)Zachary D Goodman (5 shared papers)Vinod K. Rustgi (9 shared papers)Mei-Hsiu Ling (4 shared papers)Kenneth J. Koury (3 shared papers)Robert Reindollar (8 shared papers)
- Journals
- Journal of Hepatology (54 papers)Gastroenterology (39 papers)Hepatology (20 papers)Journal of Viral Hepatitis (19 papers)Clinical Infectious Diseases (15 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Stuart C. Gordon
365 papers receiving 32.2k citations
Stuart C. Gordon's Hit Papers
Peers
Comparison fields: 5 of 161
- Hepatology 25k
- Epidemiology 5.5k
- Biological Psychiatry 87
- Pharmacology 542
- Immunology 682
Countries citing papers authored by Stuart C. Gordon
This map shows the geographic impact of Stuart C. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart C. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart C. Gordon more than expected).
Fields of papers citing papers by Stuart C. Gordon
This network shows the impact of papers produced by Stuart C. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart C. Gordon. The network helps show where Stuart C. Gordon may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart C. Gordon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 381 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Hit paper breakdown → | 2001 | 5127 |
| 2 | Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C Hit paper breakdown → | 1998 | 2948 |
| 3 | Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection Hit paper breakdown → | 2013 | 1503 |
| 4 | Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection Hit paper breakdown → | 2011 | 1341 |
| 5 | Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection Hit paper breakdown → | 2014 | 1121 |
| 6 | Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C Hit paper breakdown → | 1998 | 1119 |
| 7 | Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Hit paper breakdown → | 2019 | 1078 |
| 8 | Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis Hit paper breakdown → | 2014 | 980 |
| 9 | Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening Hit paper breakdown → | 2016 | 916 |
| 10 | Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options Hit paper breakdown → | 2013 | 907 |
| 11 | Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection Hit paper breakdown → | 2009 | 891 |
| 12 | Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection Hit paper breakdown → | 2015 | 699 |
| 13 | Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection Hit paper breakdown → | 2018 | 588 |
| 14 | Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial Hit paper breakdown → | 2010 | 570 |
| 15 | 2001 | 551 | |
| 16 | Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid Hit paper breakdown → | 2014 | 482 |
| 17 | Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection Hit paper breakdown → | 2017 | 453 |
| 18 | 2004 | 410 | |
| 19 | 2007 | 376 | |
| 20 | 2005 | 331 |
About Stuart C. Gordon
Stuart C. Gordon is a scholar working on Hepatology, Epidemiology, Insect Science, Pharmacology and Health Information Management, having authored 381 papers that have together received 34k indexed citations. Recurring topics across this work include Hepatitis C virus research (193 papers), Hepatitis B Virus Studies (53 papers), Liver Diseases and Immunity (44 papers), Liver Disease Diagnosis and Treatment (38 papers), Liver Disease and Transplantation (17 papers), Insect-Plant Interactions and Control (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). The work is most often cited by research in Hepatology (25k citations), Epidemiology (5.5k citations), Biological Psychiatry (87 citations), Pharmacology (542 citations) and Immunology (682 citations). Stuart C. Gordon has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Janice K. Albrecht, John G. McHutchison, Mitchell L. Shiffman, Zachary D Goodman, Vinod K. Rustgi, Mei-Hsiu Ling, Kenneth J. Koury, Robert Reindollar, Michael Peter Manns and Eugene R. Schiff. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Hepatology, Journal of Viral Hepatitis and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.